CEL-SCI Announces Closing of Offering
CEL-SCI Corp CVM
$1.04
▼ -5.45%
($-0.06)
Open
$1.13
Prev Close
$1.10
Day Range
$1.02 – $1.17
52W Range
$0.89 – $13.48
Market Cap
$15.07M
Beta
0.69
EPS (TTM)
$-3.58
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 1983-12-08 |
| Shares Out. | 17,480,000 |
| Website | cel-sci.com/ ↗ |
| Phone | 17035069460 |
CEL-SCI Corp is a publicly traded company under the ticker symbol CVM on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
5 analysts (2026-06-01)
📰 Latest News for CVM
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
CEL-SCI Announces Dual-Track Strategy To Bring Multikine To Patients With Head And Neck Cancer Through Parallel Regulatory Pathways In The U.S. And Saudi Arabia
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month
CEL-SCI Corporation Announces Pricing of Offering
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
CEL‑SCI To Sign Saudi Amarox Deal At BIO International Convention 2026, Advancing Multikine Commercialization In Saudi Arabia
12 Health Care Stocks Moving In Thursday's Pre-Market Session